Supported by Active Citizenship Network andendorsed the MEPs Interest Group on "European Patients' Rights & Cross-Border Healthcare", the European Parliamentary event titled “Driving Collaboration in the Fight against Antimicrobial Resistance: Going Further, Aiming Higher” was held at the EU Parliament in Brussels last 15 November 2022 with the aim to create awareness of the urgent need to leverage current EU policy developments in the fight against Antimicrobial Resistance (AMR). In particular, the EU Parliament hybrid event - organized by Weber Shandwick - reinforced the call for policy change and implementation to urgently address one of the world’s leading health threats. 

There is concrete progress and a momentum behind incentivizing antimicrobial innovations in the EU. Messages were clear and aligned:

  • AMR is urgent, #TimeToAction is critical;
  • Antimicrobial business model is broken. Incentives, especially pull, are needed;
  • EU is committed to deliver pull. There is a momentum to formalise in new pharmaceutical legislation;
  • Industry is aligned to support/collaborate/play our part;
  • The involvement of civic society and patient advocacy groups is also crucial in the development and implementation of AMR National Plans.

To sum up, the initiative aimed to raise awareness of unmet needs in the fight against AMR as well as to identify and implement tangible policy action across EU Member States to result in behavioural and societal change.

For further information, please click here or write to Weber Shandwick team.


11am-12.30pm CET
EuropeanParliament (RoomA3E-2), Bruxelles



Opening remarks (15’)


Panel discussion 1: Incentivising innovation in AMR (35’)

  • Nobuko Ichikawa, Senior Environmental and AMR Consultant for the European Bank for Reconstruction and Development (EBRD)
  • Christine Oline Årdal, Norwegian Public Health Institute (virtual)
  • Aleksandra Opalska, DG SANTE, European Commission (virtual)


Panel Discussion 2: Looking ahead – driving sustainable collaborations to address unmet needs (30’)

  • Jan De Maeseneer, Chair of the Expert Panel on effective ways in investing in health (virtual)
  • Cristina Muñoz Madero, Head of Clinical and Pre-Clinical Area, Coordinator of the Spanish National Plan on AMR, Spanish Agency for Medicines and Medical Devices, AEMPS (virtual)
  • Keiko Tone, UK General Manager, Shionogi


Concluding remarks (10’)

  • Final thoughts from all panellists


To know more:

Subscribe to the newsletter

Valore non valido

Valore non valido

Valore non valido

Valore non valido

Valore non valido